129 related articles for article (PubMed ID: 38377734)
21. MiR-328 promotes glioma cell invasion via SFRP1-dependent Wnt-signaling activation.
Delic S; Lottmann N; Stelzl A; Liesenberg F; Wolter M; Götze S; Zapatka M; Shiio Y; Sabel MC; Felsberg J; Reifenberger G; Riemenschneider MJ
Neuro Oncol; 2014 Jan; 16(2):179-90. PubMed ID: 24305703
[TBL] [Abstract][Full Text] [Related]
22. Targeting the Notch1 oncogene by miR-139-5p inhibits glioma metastasis and epithelial-mesenchymal transition (EMT).
Li J; Li Q; Lin L; Wang R; Chen L; Du W; Jiang C; Li R
BMC Neurol; 2018 Aug; 18(1):133. PubMed ID: 30170559
[TBL] [Abstract][Full Text] [Related]
23. Novel internal regulators and candidate miRNAs within miR-379/miR-656 miRNA cluster can alter cellular phenotype of human glioblastoma.
Nayak S; Aich M; Kumar A; Sengupta S; Bajad P; Dhapola P; Paul D; Narta K; Purkrait S; Mehani B; Suri A; Chakraborty D; Mukhopadhyay A; Sarkar C
Sci Rep; 2018 May; 8(1):7673. PubMed ID: 29769662
[TBL] [Abstract][Full Text] [Related]
24. Identification and functional characterization of microRNAs involved in the malignant progression of gliomas.
Malzkorn B; Wolter M; Liesenberg F; Grzendowski M; Stühler K; Meyer HE; Reifenberger G
Brain Pathol; 2010 May; 20(3):539-50. PubMed ID: 19775293
[TBL] [Abstract][Full Text] [Related]
25. Diagnostic, grading and prognostic role of a restricted miRNAs signature in primary and metastatic brain tumours. Discussion on their therapeutic perspectives.
Nikolova E; Georgiev C; Laleva L; Milev M; Spiriev T; Stoyanov S; Taseva-Mineva T; Mitev V; Todorova A
Mol Genet Genomics; 2022 Mar; 297(2):357-371. PubMed ID: 35064290
[TBL] [Abstract][Full Text] [Related]
26. miR-542-3p Contributes to the HK2-Mediated High Glycolytic Phenotype in Human Glioma Cells.
Kim J; Park MW; Park YJ; Ahn JW; Sim JM; Kim S; Heo J; Jeong JH; Lee M; Lim J; Moon JS
Genes (Basel); 2021 Apr; 12(5):. PubMed ID: 33922649
[TBL] [Abstract][Full Text] [Related]
27. Hypoxic signature of microRNAs in glioblastoma: insights from small RNA deep sequencing.
Agrawal R; Pandey P; Jha P; Dwivedi V; Sarkar C; Kulshreshtha R
BMC Genomics; 2014 Aug; 15(1):686. PubMed ID: 25129238
[TBL] [Abstract][Full Text] [Related]
28. Methylation of the miR-126 gene associated with glioma progression.
Cui H; Mu Y; Yu L; Xi YG; Matthiesen R; Su X; Sun W
Fam Cancer; 2016 Apr; 15(2):317-24. PubMed ID: 26463235
[TBL] [Abstract][Full Text] [Related]
29. miRNA Regulation in Gliomas: Usual Suspects in Glial Tumorigenesis and Evolving Clinical Applications.
Ames H; Halushka MK; Rodriguez FJ
J Neuropathol Exp Neurol; 2017 Apr; 76(4):246-254. PubMed ID: 28431179
[TBL] [Abstract][Full Text] [Related]
30. MiR-1224-5p acts as a tumor suppressor by targeting CREB1 in malignant gliomas.
Qian J; Li R; Wang YY; Shi Y; Luan WK; Tao T; Zhang JX; Xu YC; You YP
Mol Cell Biochem; 2015 May; 403(1-2):33-41. PubMed ID: 25648114
[TBL] [Abstract][Full Text] [Related]
31. Microrna-1224-5p Is a Potential Prognostic and Therapeutic Biomarker in Glioblastoma: Integrating Bioinformatics and Clinical Analyses.
Wei X; Zhang QM; Liu C; Wu S; Nong WX; Ge YY; Lin LN; Li F; Xie XX; Luo B
Curr Med Sci; 2022 Jun; 42(3):584-596. PubMed ID: 35678909
[TBL] [Abstract][Full Text] [Related]
32. MicroRNA-34a-5p suppresses tumorigenesis and progression of glioma and potentiates Temozolomide-induced cytotoxicity for glioma cells by targeting HMGA2.
Ma S; Fu T; Zhao S; Gao M
Eur J Pharmacol; 2019 Jun; 852():42-50. PubMed ID: 30851271
[TBL] [Abstract][Full Text] [Related]
33. Methylation associated miR-1246 contributes to poor prognosis in gliomas treated with temozolomide.
Wang H; Wu B; Wang J; Hu Y; Dai X; Ye L; Cheng H
Clin Neurol Neurosurg; 2021 Jan; 200():106344. PubMed ID: 33153768
[TBL] [Abstract][Full Text] [Related]
34. Identification of Dysregulated microRNAs in Glioma Using RNA-sequencing.
Liu C; Ge YY; Xie XX; Luo B; Shen N; Liao XS; Bi SQ; Xu T; Xiao SW; Zhang QM
Curr Med Sci; 2021 Apr; 41(2):356-367. PubMed ID: 33877554
[TBL] [Abstract][Full Text] [Related]
35. Comprehensive analysis of the functional microRNA-mRNA regulatory network identifies miRNA signatures associated with glioma malignant progression.
Li Y; Xu J; Chen H; Bai J; Li S; Zhao Z; Shao T; Jiang T; Ren H; Kang C; Li X
Nucleic Acids Res; 2013 Dec; 41(22):e203. PubMed ID: 24194606
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of glioblastoma cell invasion by hsa-miR-145-5p and hsa-miR-31-5p co-overexpression in human mesenchymal stem cells.
Kurogi R; Nakamizo A; Suzuki SO; Mizoguchi M; Yoshimoto K; Amano T; Amemiya T; Takagishi S; Iihara K
J Neurosurg; 2018 Mar; 130(1):44-55. PubMed ID: 29521593
[TBL] [Abstract][Full Text] [Related]
37. MiR-30a-5p antisense oligonucleotide suppresses glioma cell growth by targeting SEPT7.
Jia Z; Wang K; Wang G; Zhang A; Pu P
PLoS One; 2013; 8(1):e55008. PubMed ID: 23383034
[TBL] [Abstract][Full Text] [Related]
38. The Mechanisms of Current Platinum Anticancer Drug Resistance in the Glioma.
Lu E; Gareev I; Yuan C; Liang Y; Sun J; Chen X; Beylerli O; Sufianov A; Zhao S; Yang G
Curr Pharm Des; 2022; 28(23):1863-1869. PubMed ID: 35674307
[TBL] [Abstract][Full Text] [Related]
39. A miRNA signature for defining aggressive phenotype and prognosis in gliomas.
Barbano R; Palumbo O; Pasculli B; Galasso M; Volinia S; D'Angelo V; Icolaro N; Coco M; Dimitri L; Graziano P; Copetti M; Valori VM; Maiello E; Carella M; Fazio VM; Parrella P
PLoS One; 2014; 9(10):e108950. PubMed ID: 25279461
[TBL] [Abstract][Full Text] [Related]
40. Propolis Extract Regulates microRNA Expression in Glioblastoma and Brain Cancer Stem Cells.
C Yilmaz U; Bagca BG; Karaca E; Durmaz A; Durmaz B; Aykut A; Kayalar H; Avci CB; Susluer SY; Pariltay E; Gunduz C; Cogulu O
Anticancer Agents Med Chem; 2022; 22(2):378-389. PubMed ID: 33949939
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]